Social AnxietyVIRTUSNCT06379633
Virtual Reality Exposure for Socially Anxious Adolescents
A study testing In vivo exposure and (Virtual reality) exposure in people with Social Anxiety, run by KU Leuven at 1 site in Belgium.
Trial summary
Overall in this project, the primary goal is to evaluate the efficacy of virtual reality exposure (VRE) for adolescents with elevated social anxiety using a three-arm randomized controlled trial: (1) virtual reality exposure (VRE); (2) in vivo exposure (IVE); and (3) waitlist (WL) - the control condition. Read more about this study
- Who is it for?
- Ages 12 to 16 years
- Conditions the study is for
- Social Anxiety
- What is being tested?
- In vivo exposure and (Virtual reality) exposure
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 120 participants
- Where
- 1 siteBelgium
- Study dates
- 27 Mar 2024to Jun 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 to 16 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Elevated levels of social anxiety (as per the Social Phobia Inventory; ≥ 19)
- Fluent in Dutch
- 12-16 years old
Who cannot join
- Severe social anxiety disorder
- Severe depression
- Psychotic symptoms
- Severe suicidal thoughts and / or severe self-harm
- Severe substance use
- Benzodiazepine use and / or a change of psychoactive medication usage (dose, type)
Show all 15Show fewer
- Autism spectrum disorder (ASD) diagnosis
- Current ongoing psychological treatment (or waitlisted) for anxiety disorders and or depression
- Other urgent psychopathologies and/or mismatch between participants' clinical presentation and the offered training
- Exposure therapy for social anxiety disorder in the past 2 years
- Another person from the same household is participating in the study
- Eligible for VR as per the following criteria:
- History of extreme/severe motion sickness (e.g., car sick, sea-sick) and / or experiencing extreme/severe symptoms of motion sickness during 3D movies
- Stereoscopic vision problem or a balance problem that would hinder the VR experience;
- History of seizures, seizure disorder or epilepsy
Trial locations and contacts
1 site in 1 country.
Belgium1 site, 1 recruiting
- Recruiting
Psychological Institute (PSI) of KU Leuven
Leuven, 3000 Leuven
Jella De Lee, MSc, +3216373075, jella.delee@kuleuven.be
Elizabeth S. Uduwa-vidanalage, MSc, s.e.uduwavidanalage@uu.nl
About this study
Official title: Virtual Reality Exposure for Socially Anxious Adolescents: A Randomized Controlled Trial (RCT)
Overall in this project, the primary goal is to evaluate the efficacy of virtual reality exposure (VRE) for adolescents with elevated social anxiety using a three-arm randomized controlled trial: (1) virtual reality exposure (VRE); (2) in vivo exposure (IVE); and (3) waitlist (WL) - the control condition.
It is predicted that both VRE and IVE will be more successful in decreasing social anxiety symptoms than the WL condition at post-assessment and that VRE will be as effective as in vivo in reducing social anxiety symptoms. Furthermore, it is expected that there will be no difference between the two active conditions in the long term (at 3- months \& 6-months follow up). Similar results are expected in the secondary outcome measures, intended to capture the participants' general well-being.
Read more
Moreover, the study has the following (secondary) objectives:
- To elucidate potential working mechanisms of VRE and IVE
- To identify predictors of adolescents' response to VRE and IVE
- To assess to what extent adolescents accept VRE and IVE and how they experience it
Read the detailed description
This study is going to be a single-blinded, randomized controlled trial (RCT) with three arms: VRE, IVE, and a WL condition. It will follow a mixed-subjects design with condition as a between factor and measurement time-points as a within factor. Due to the study's goal to unravel the effects of VRE, the focus of the intervention will be on exposure in both active conditions (without explicitly including other treatment components like cognitive restructuring). The intervention will take place either at participants' schools or at KU Leuven (i.e., PraxisP - the outpatient treatment facility of the Faculty of Psychology and Educational Sciences, PSI - Psychological Institute) depending on the participants' preference and availability. In case this is not possible, neighboring healthcare practices will be explored as an alternative option. In any case, the training will be held in a separate, private room where the privacy of the participant can be guaranteed. Each active condition will comprise of 7 training sessions in total approximately 90 minutes each.
At pre-assessment, all primary and secondary outcome measures and most of the predictors will be assessed approximately one week prior to the first session. The outcome measures will be re-assessed during the post-assessment (one week after the last session) and the follow up assessments (3-months \& 6-months following the post assessment). During the training sessions, measurements of the mechanisms, remaining predictors, and participant feedback will be acquired and at mid-assessment an additional measurement of the primary outcome measures (e.g., social anxiety measures) will be obtained. Moreover, a brief social anxiety measure will also be conducted on a weekly basis to record symptom-related changes from session to session. Following the training, a qualitative interview will be conducted. This semi-structured interview will be conducted in a convenience sample of participants from both active conditions (e.g., 10-16 participants per condition due to pragmatic considerations and based on general recommendations as to when theoretical data saturation can be reached) to investigate VRE's acceptability and to compare it to IVE. To decrease demand effects, the (online) interview will be conducted by an independent interviewer (e.g., not the therapist) and will be audio-taped so that the interviewer can focus solely on the interaction.
Moreover, in line with good clinical practice and individualized treatment, the specific nature and content of the exposure exercises will be determined for each participant individually by presenting them with an extensive list of the possible exercises (e.g., ordering food in a restaurant, asking a question in class, engaging in a group conversation) in combination with a functional analysis. To ensure that the active conditions are comparable, the IVE condition will be matched to the VRE condition in terms of exposure duration and homework assignments will not be actively encouraged in both conditions. The crucial difference between the two active conditions is that in the IVE condition the exercises take place in real life, whereas in VRE the exercises take place in virtual reality. For the WL condition, the (primary and secondary) outcome measures will be administered before, during, and after the given waiting period (i.e., duration of training sessions) at the same instances as with the active conditions. After that time, participants in the WL condition will have the opportunity to be randomized into IVE and VRE.
- Conditions
- Social Anxiety
- Being tested
- In vivo exposure, (Virtual reality) exposure
- Keywords
- virtual reality exposure, social anxiety, adolescents, inhibitory learning theory, predictors, youth, mental health, mechanisms
- Medical subject headings
- Psychological Well-Being
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
In vivo exposureBehavioural
Exposure in vivo involves the confrontation with fear-evoking situations in real life.
(Virtual reality) exposureBehavioural
Exposure in virtual reality involves the confrontation with fear-evoking situations which are generated by a computer using VR technology.
| Study group | Role | What they receive |
|---|---|---|
| Virtual reality exposure (VRE) | Experimental | Participants in the VRE condition will be exposed to various VR-based one-on-one and group social interactions which tend to elicit anxiety. That is, commonly feared situations and events (e.g., raising your hand in class, saying no to a friend, ordering food at a restaurant, calling a classmate to invite them to hang out) will be recreated in the virtual environments. Exercises will be tailored to the participant and provided by clinical psychologists under supervision of experienced CBT therapists (and supervisors). To deliver VRE we will utilize a dynamic and interactive VR-software called 'Social Worlds' developed by CleVR. It has various functions and capabilities (e.g., role-playing, walking around, change of perspective, alteration of dialogue style, number of avatars present in the virtual environment) which enables individualized exposure. Receives: Behavioral: (Virtual reality) exposure |
| In vivo exposure (IVE) | Active comparator | Similarly to VRE, participants in the IVE condition will be exposed to various one-on-one and group social interactions which tend to elicit anxiety, but they will do so in real-life. The exposure exercises here also will be determined in consultation with the participant. Depending on the given exposure exercise, exposure will either take place at the training location or in its neighborhood (e.g., nearby supermarkets, subway stations, cafes, buses). Exercises will be tailored to the participant and provided by clinical psychologists under supervision of experienced CBT therapists (and supervisors). Importantly, participants will undergo the same amount of exposure sessions as in the VRE condition (to keep exposure time constant). Receives: Behavioral: In vivo exposure |
| Waitlist | No intervention | The participants in the WL condition will complete the assessments at the same time points as in the active conditions but will not receive any of the sessions until post-assessment has been completed. Then they will be randomly assigned to one of the two active conditions (VRE or IVE). |
What is being measured
The primary outcome is the main question the study is designed to answer.
Brief version of the Social Phobia and Anxiety Inventory (SPAI-18)
General measure of social anxiety
Measured: Pre-assessment, after 4 weeks, after 8 weeks, follow-up(after 20 weeks), follow up(after 32 weeks)* *Due to practical reasons (e.g., school vacation) the exact number of weeks may change. This applies for all the timepoints except pre-assessment.
Liebowitz Social Anxiety Scale for Children and Adolescents (LSAS-CA) - Avoidance subscale
Avoidance measure of social anxiety
Measured: Pre-assessment, after 4 weeks, after 8 weeks, follow-up(after 20 weeks), follow up(after 32 weeks)*
Behavioral assessment task (BAT) - Peak anxiety
Subjective units of distress (SUD) measured on a visual analogue scale (VAS); administered immediately after the BAT
Measured: Pre-assessment, after 8 weeks*
Secondary outcomes (13)
Brief Resilience Scale (BRS)
General measure of resilience
Measured: Pre-assessment, after 4 weeks, after 8 weeks, follow-up(after 20 weeks), follow up(after 32 weeks)*
Multidimensional Adolescent Functioning Scale (MAFS) - Peer and General functioning subscales
General measure of psychosocial functioning
Measured: Pre-assessment, after 4 weeks, after 8 weeks, follow-up(after 20 weeks), follow up(after 32 weeks)*
Revised Children's Anxiety and Depression Scale (RCADS)
General measure of depression and anxiety + Predictor
Measured: Pre-assessment, after 4 weeks, after 8 weeks, follow-up(after 20 weeks), follow up(after 32 weeks)*
Self-Efficacy Questionnaire for Children (SEQ-C) - Social efficacy subscale
General measure of social self efficacy and mechanism
Measured: Pre-assessment, after 4 weeks, after 8 weeks, follow-up(after 20 weeks), follow up(after 32 weeks)*
Social Phobia Weekly Summary Scale (SPWSS)
Weekly measure of social anxiety
Measured: Pre-assessment, every training week (up to 7 weeks after pre-assessment), after 8 weeks, follow-up(after 20 weeks), follow up(after 32 weeks)*
Liebowitz Social Anxiety Scale for Children and Adolescents (LSAS-CA) - Fear subscale
Secondary measure of fear regarding specific social situations
Measured: Pre-assessment, after 4 weeks, after 8 weeks, follow-up(after 20 weeks), follow up(after 32 weeks)*
Adolescent Social Cognitions Questionnaire (ASCQ)
Secondary outcome and mechanism \& predictor
Measured: Pre-assessment, after 8 weeks, follow-up(after 20 weeks), follow up(after 32 weeks)*
Behavioral assessment task (BAT) - Anticipatory anxiety
Subjective units of distress (SUD) measured on a visual analogue scale (VAS) immediately before the BAT
Measured: Pre-assessment, after 8 weeks*
Behavioral assessment task (BAT) - Physiological assessment
Mean heart rate measured during the BAT
Measured: Pre-assessment, after 8 weeks*
Behavioral assessment task (BAT) - Physiological assessment
Heart-rate variability measured during the BAT
Measured: Pre-assessment, after 8 weeks*
Behavioral assessment task (BAT) - Physiological assessment
Skin conductance response measured during the BAT
Measured: Pre-assessment, after 8 weeks*
Behavioral assessment task (BAT) - Task duration
Duration of task in seconds
Measured: Pre-assessment, after 8 weeks*
Behavioral assessment task (BAT) - Confederate rating
During the BAT, the confederate will rate the participants' social anxiety and performance on a 5-point Likert scale
Measured: Pre-assessment, after 8 weeks*
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Apr 2024
- Study start27 Mar 2024
- Primary completionJun 2026 (estimated)
- Study completionJun 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Social AnxietyStudies of the same condition, open and under way.
- More trials run by KU LeuvenThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants will be randomly assigned to one of the three conditions and will remain in that condition throughout the training sessions.
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 120 participants (estimated)
Sponsor and investigators
- Lead sponsor
- KU Leuven
- Sponsor type
- University, hospital or other
- Collaborators
- Utrecht University
- Responsible party
- Principal investigator, Dirk Hermans, KU Leuven
- Investigators
- Dirk Hermans, PhD, Principal investigator, KU Leuven
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06379633
- Sponsor's protocol ID
- s67010
- Acronym
- VIRTUS
- Status last verified
- Apr 2024
- First submitted
- 2 Apr 2024
- Last updated
- 23 Apr 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: There are no concrete plans to upload individual participant data on to any platforms. However, if other researchers request for the pseudo-anonymized data, then an agreement can be made to share the data.
Publications
Uduwa Vidanalage ES, De Lee J, Hermans D, Engelhard IM, Scheveneels S, Meyerbroker K. VIRTUS: virtual reality exposure training for adolescents with social anxiety - a randomized controlled trial. BMC Psychiatry. 2025 Apr 18;25(1):401. doi: 10.1186/s12888-025-06756-w.
PubMed 40251576
Study at a glance
From the registry record, last updated by the sponsor on 23 Apr 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Virtual Reality Exposure for Socially Anxious Adolescents: A Randomized Controlled Trial (RCT)
- ClinicalTrials.gov ID
- NCT06379633
- Acronym / sponsor ID
- VIRTUS / s67010
- Conditions
- Social Anxiety
- Keywords
- virtual reality exposure, social anxiety, adolescents, inhibitory learning theory, predictors, youth, mental health, mechanisms
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 120 participants (estimated)
- Lead sponsor
- KU LeuvenUniversity, hospital or other
- Collaborators
- Utrecht University
- Study start
- 27 Mar 2024 (actual)
- Primary completion
- Jun 2026 (estimated)
- Study completion
- Jun 2026 (estimated)
- First posted
- 23 Apr 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Overall in this project, the primary goal is to evaluate the efficacy of virtual reality exposure (VRE) for adolescents with elevated social anxiety using a three-arm randomized controlled trial: (1) virtual reality exposure (VRE); (2) in vivo exposure (IVE); and (3) waitlist (WL) - the control condition.
It is predicted that both VRE and IVE will be more successful in decreasing social anxiety symptoms than the WL condition at post-assessment and that VRE will be as effective as in vivo in reducing social anxiety symptoms. Furthermore, it is expected that there will be no difference between the two active conditions in the long term (at 3- months \& 6-months follow up). Similar results are expected in the secondary outcome measures, intended to capture the participants' general well-being.
Moreover, the study has the following (secondary) objectives:
- To elucidate potential working mechanisms of VRE and IVE
- To identify predictors of adolescents' response to VRE and IVE
- To assess to what extent adolescents accept VRE and IVE and how they experience it
Detailed description
This study is going to be a single-blinded, randomized controlled trial (RCT) with three arms: VRE, IVE, and a WL condition. It will follow a mixed-subjects design with condition as a between factor and measurement time-points as a within factor. Due to the study's goal to unravel the effects of VRE, the focus of the intervention will be on exposure in both active conditions (without explicitly including other treatment components like cognitive restructuring). The intervention will take place either at participants' schools or at KU Leuven (i.e., PraxisP - the outpatient treatment facility of the Faculty of Psychology and Educational Sciences, PSI - Psychological Institute) depending on the participants' preference and availability. In case this is not possible, neighboring healthcare practices will be explored as an alternative option. In any case, the training will be held in a separate, private room where the privacy of the participant can be guaranteed. Each active condition will comprise of 7 training sessions in total approximately 90 minutes each.
At pre-assessment, all primary and secondary outcome measures and most of the predictors will be assessed approximately one week prior to the first session. The outcome measures will be re-assessed during the post-assessment (one week after the last session) and the follow up assessments (3-months \& 6-months following the post assessment). During the training sessions, measurements of the mechanisms, remaining predictors, and participant feedback will be acquired and at mid-assessment an additional measurement of the primary outcome measures (e.g., social anxiety measures) will be obtained. Moreover, a brief social anxiety measure will also be conducted on a weekly basis to record symptom-related changes from session to session. Following the training, a qualitative interview will be conducted. This semi-structured interview will be conducted in a convenience sample of participants from both active conditions (e.g., 10-16 participants per condition due to pragmatic considerations and based on general recommendations as to when theoretical data saturation can be reached) to investigate VRE's acceptability and to compare it to IVE. To decrease demand effects, the (online) interview will be conducted by an independent interviewer (e.g., not the therapist) and will be audio-taped so that the interviewer can focus solely on the interaction.
Moreover, in line with good clinical practice and individualized treatment, the specific nature and content of the exposure exercises will be determined for each participant individually by presenting them with an extensive list of the possible exercises (e.g., ordering food in a restaurant, asking a question in class, engaging in a group conversation) in combination with a functional analysis. To ensure that the active conditions are comparable, the IVE condition will be matched to the VRE condition in terms of exposure duration and homework assignments will not be actively encouraged in both conditions. The crucial difference between the two active conditions is that in the IVE condition the exercises take place in real life, whereas in VRE the exercises take place in virtual reality. For the WL condition, the (primary and secondary) outcome measures will be administered before, during, and after the given waiting period (i.e., duration of training sessions) at the same instances as with the active conditions. After that time, participants in the WL condition will have the opportunity to be randomized into IVE and VRE.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 3
- Model description
- Participants will be randomly assigned to one of the three conditions and will remain in that condition throughout the training sessions.
| Arm | Type | Receives |
|---|---|---|
| Virtual reality exposure (VRE) | Experimental | Behavioral: (Virtual reality) exposureParticipants in the VRE condition will be exposed to various VR-based one-on-one and group social interactions which tend to elicit anxiety. That is, commonly feared situations and events (e.g., raising your hand in class, saying no to a friend, ordering food at a restaurant, calling a classmate to invite them to hang out) will be recreated in the virtual environments. Exercises will be tailored to the participant and provided by clinical psychologists under supervision of experienced CBT therapists (and supervisors). To deliver VRE we will utilize a dynamic and interactive VR-software called 'Social Worlds' developed by CleVR. It has various functions and capabilities (e.g., role-playing, walking around, change of perspective, alteration of dialogue style, number of avatars present in the virtual environment) which enables individualized exposure. |
| In vivo exposure (IVE) | Active comparator | Behavioral: In vivo exposureSimilarly to VRE, participants in the IVE condition will be exposed to various one-on-one and group social interactions which tend to elicit anxiety, but they will do so in real-life. The exposure exercises here also will be determined in consultation with the participant. Depending on the given exposure exercise, exposure will either take place at the training location or in its neighborhood (e.g., nearby supermarkets, subway stations, cafes, buses). Exercises will be tailored to the participant and provided by clinical psychologists under supervision of experienced CBT therapists (and supervisors). Importantly, participants will undergo the same amount of exposure sessions as in the VRE condition (to keep exposure time constant). |
| Waitlist | No intervention | –The participants in the WL condition will complete the assessments at the same time points as in the active conditions but will not receive any of the sessions until post-assessment has been completed. Then they will be randomly assigned to one of the two active conditions (VRE or IVE). |
Who may qualify
- Ages
- 12 to 16 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (3 listed)
- Elevated levels of social anxiety (as per the Social Phobia Inventory; ≥ 19)
- Fluent in Dutch
- 12-16 years old
Key exclusion criteria (15 listed)
- Severe social anxiety disorder
- Severe depression
- Psychotic symptoms
- Severe suicidal thoughts and / or severe self-harm
- Severe substance use
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| In vivo exposureExposure in vivo involves the confrontation with fear-evoking situations in real life. | Behavioural | In vivo exposure (IVE) |
| (Virtual reality) exposureExposure in virtual reality involves the confrontation with fear-evoking situations which are generated by a computer using VR technology. | Behavioural | Virtual reality exposure (VRE) |
Primary outcome
Brief version of the Social Phobia and Anxiety Inventory (SPAI-18)
Time frame: Pre-assessment, after 4 weeks, after 8 weeks, follow-up(after 20 weeks), follow up(after 32 weeks)* *Due to practical reasons (e.g., school vacation) the exact number of weeks may change. This applies for all the timepoints except pre-assessment.
General measure of social anxiety
Liebowitz Social Anxiety Scale for Children and Adolescents (LSAS-CA) - Avoidance subscale
Time frame: Pre-assessment, after 4 weeks, after 8 weeks, follow-up(after 20 weeks), follow up(after 32 weeks)*
Avoidance measure of social anxiety
Behavioral assessment task (BAT) - Peak anxiety
Time frame: Pre-assessment, after 8 weeks*
Subjective units of distress (SUD) measured on a visual analogue scale (VAS); administered immediately after the BAT
13 secondary outcomes
Brief Resilience Scale (BRS)
Time frame: Pre-assessment, after 4 weeks, after 8 weeks, follow-up(after 20 weeks), follow up(after 32 weeks)*
Multidimensional Adolescent Functioning Scale (MAFS) - Peer and General functioning subscales
Time frame: Pre-assessment, after 4 weeks, after 8 weeks, follow-up(after 20 weeks), follow up(after 32 weeks)*
Revised Children's Anxiety and Depression Scale (RCADS)
Time frame: Pre-assessment, after 4 weeks, after 8 weeks, follow-up(after 20 weeks), follow up(after 32 weeks)*
Self-Efficacy Questionnaire for Children (SEQ-C) - Social efficacy subscale
Time frame: Pre-assessment, after 4 weeks, after 8 weeks, follow-up(after 20 weeks), follow up(after 32 weeks)*
Social Phobia Weekly Summary Scale (SPWSS)
Time frame: Pre-assessment, every training week (up to 7 weeks after pre-assessment), after 8 weeks, follow-up(after 20 weeks), follow up(after 32 weeks)*
Liebowitz Social Anxiety Scale for Children and Adolescents (LSAS-CA) - Fear subscale
Time frame: Pre-assessment, after 4 weeks, after 8 weeks, follow-up(after 20 weeks), follow up(after 32 weeks)*
Adolescent Social Cognitions Questionnaire (ASCQ)
Time frame: Pre-assessment, after 8 weeks, follow-up(after 20 weeks), follow up(after 32 weeks)*
Behavioral assessment task (BAT) - Anticipatory anxiety
Time frame: Pre-assessment, after 8 weeks*
Behavioral assessment task (BAT) - Physiological assessment
Time frame: Pre-assessment, after 8 weeks*
Behavioral assessment task (BAT) - Physiological assessment
Time frame: Pre-assessment, after 8 weeks*
Behavioral assessment task (BAT) - Physiological assessment
Time frame: Pre-assessment, after 8 weeks*
Behavioral assessment task (BAT) - Task duration
Time frame: Pre-assessment, after 8 weeks*
Behavioral assessment task (BAT) - Confederate rating
Time frame: Pre-assessment, after 8 weeks*
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Apr 2024.
- Derived from this study: PubMed 40251576Uduwa Vidanalage ES, De Lee J, Hermans D, Engelhard IM, Scheveneels S, Meyerbroker K. VIRTUS: virtual reality exposure training for adolescents with social anxiety - a randomized controlled trial. BMC Psychiatry. 2025 Apr 18;25(1):401. doi: 10.1186/s12888-025-06756-w.
- Individual participant dataSharing planned: No. There are no concrete plans to upload individual participant data on to any platforms. However, if other researchers request for the pseudo-anonymized data, then an agreement can be made to share the data.
Related trials for Social Anxiety
Recruiting
Comprehensive Assessment of Rehabilitation Experience Using the SAFE Scale
Caregiver Anxiety, Acquired Brain Injury
Not yet recruiting
Online Study on the Impact of a Self-Help Tool for Social Anxiety
Social Anxiety
Active, not recruiting
Targeting Social Function in Anxiety and Eating Disorders
Eating Disorders, Anorexia Nervosa
Not yet recruiting
Effect of Short-Video Distraction During Burn Dressing on Anxiety, Pain, and Fear in Children
Burn Injury, Procedural Anxiety
Active, not recruiting
Future School of Comprehensive Well-Being
Learning, Comprehensive Wellbeing
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Dirk Hermans, PhD principal investigator
KU Leuven
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing In vivo exposure and (Virtual reality) exposure in people with Social Anxiety, run by KU Leuven at 1 site in Belgium.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 23 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Elizabeth S. Uduwa-vidanalage, MSc (+31 638727709, s.e.uduwavidanalage@uu.nl), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Brief version of the Social Phobia and Anxiety Inventory (SPAI-18) (time frame: Pre-assessment, after 4 weeks, after 8 weeks, follow-up(after 20 weeks), follow up(after 32 weeks)* *Due to practical reasons (e.g., school vacation) the exact number of weeks may change. This applies for all the timepoints except pre-assessment.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06379633, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Apr 2024.